FeesSafety
Pluang+

Tectonic Therapeutic CEO to speak at two major healthcare investor conferences in Nov-Dec 2026

Market News
09 Nov 2026, 15:00 WIB
GlobeNewsWire
View Source
Neutral
Tectonic Therapeutic CEO to speak at two major healthcare investor conferences in Nov-Dec 2026

Tectonic Therapeutic announced that CEO Alise Reicin will participate in fireside chats at the Stifel 2026 Healthcare Conference on November 11 and the Piper Sandler 38th Annual Healthcare Conference on December 2. These events provide an opportunity for investors to hear directly from the company leadership about its clinical-stage biotech developments focused on GPCR-targeted therapies. Webcasts of the sessions will be available on Tectonic's website, and the management team will hold one-on-one meetings with investors during the conferences. This engagement aims to increase investor awareness and interest in Tectonic's innovative therapeutic programs.

Tectonic Therapeutic's upcoming investor conference participation is noted here with Pluang's Health-sector market data as of Nov 09, 2026 19:41 WIB: out of 150 priced Health-sector US stocks tradable on Pluang, 121 rose and 18 fell today. Key movers include ROIV at USD 40.25 (+3.52%), NUWE at USD 4.72 (+3.06%), and CTXR at USD 0.54 (-2.98%). The most notable figure is ROIV's 3.52% gain.

More News

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...

Market News
Neutral
20 minutes ago
New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...

Company Fundamentals
Bullish
1 hour ago
Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...

Bearish
1 hour ago
Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave Intelligence plc has introduced Octave Attune Facilities, a cloud-based software solution designed to help organizations manage multiple sites with AI-powered tools. This platform integrates building, space, maintenance, and operational data t...

Market News
Bullish
1 hour ago
ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App